Annual EBITDA
-$101.37M$43.06M-73.84%
Summary
- Current Value
- As of today, CELC annual EBITDA is -$101.37M, down -73.84% on
- Historical Performance
- CELC annual EBITDA is down -261.52% over the past 3 years, and down -1343.96% over the past 5 years
- All-Time High Comparison
- CELC annual EBITDA is currently -4500.56% below its historical high of -$2.20M set on
- 3-Year Low Comparison
- CELC annual EBITDA is at its 3-year low
- Sector Comparison
- CELC annual EBITDA is higher than 16.96% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$101.37M | -73.8% | -261.5% | -1344.0% | -4500.6% | |
| Quarterly EBITDA | -$42.81M | -42.6% | -304.2% | -1696.0% | -5992.8% | |
| TTM EBITDA | -$159.27M | -65.1% | -370.5% | -1769.0% | -10000.0% | |
| Price | $104.67 | +724.2% | +770.1% | +822.2% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual EPS | -$2.83 | -5.2% | -28.1% | -293.7% | -10000.0% | |
| Annual EBIT | -$101.50M | -73.6% | -258.1% | -1279.2% | -4387.5% | |
| Annual Net Income | -$111.78M | -75.3% | -277.6% | -1418.9% | -4842.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$38.05M | N/A | -166.4% |
| 5Y | -$9.09M | N/A | -1015.4% |
| All | -$2.20M | -4500.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$101.37M | at low | |
| 5Y | -$101.37M | at low | |
| All | -$101.37M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$101.37M | -73.8% | |
| -$58.31M | -53.2% | |
| -$38.05M | -35.7% | |
| -$28.04M | -208.5% | |
| -$9.09M | -29.5% |
| Year | Value | Change |
|---|---|---|
| -$7.02M | +3.3% | |
| -$7.26M | -27.4% | |
| -$5.70M | -75.9% | |
| -$3.24M | -46.9% | |
| -$2.20M | - |
FAQ
What is the current annual EBITDA of CELC?
As of today, CELC annual EBITDA is -$101.37M
What is 1-year change in CELC annual EBITDA?
CELC annual EBITDA is down -73.84% year-over-year
What is 3-year change in CELC annual EBITDA?
CELC annual EBITDA is down -261.52% over the past 3 years
How far is CELC annual EBITDA from its all-time high?
CELC annual EBITDA is currently -4500.56% below its historical high of -$2.20M set on December 31, 2015
How does CELC annual EBITDA rank versus sector peers?
CELC annual EBITDA is higher than 16.96% of companies in Healthcare sector
When is CELC next annual earnings release?
The next annual earnings release for CELC is on
Quarterly EBITDA
-$42.81M$1.16M+2.64%
Summary
- Current Value
- As of today, CELC quarterly EBITDA is -$42.81M, up +2.64% on
- Historical Performance
- CELC quarterly EBITDA is down -42.57% year-over-year, and down -304.23% over the past 3 years
- All-Time High Comparison
- CELC quarterly EBITDA is currently -5992.80% below its historical high of -$702.60K set on
- 3-Year Low Comparison
- CELC quarterly EBITDA is +2.64% above its 3-year low of -$43.97M reached on
- Sector Comparison
- CELC quarterly EBITDA is higher than 9.30% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$42.81M | +2.6% | -42.6% | -304.2% | -1696.0% | |
| Annual EBITDA | -$101.37M | – | -73.8% | -261.5% | -1344.0% | |
| TTM EBITDA | -$159.27M | -8.7% | -65.1% | -370.5% | -1769.0% | |
| Price | $104.67 | +111.5% | +724.2% | +770.1% | +822.2% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly EPS | -$0.92 | +11.2% | -32.2% | -26.2% | -282.2% | |
| Quarterly EBIT | -$42.85M | +2.6% | -42.5% | -302.6% | -1627.7% | |
| Quarterly Net Income | -$43.80M | +3.2% | -47.0% | -302.1% | -1670.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$36.10M | -18.6% | |
| 3Y | -$11.59M | N/A | -269.3% |
| 5Y | -$2.45M | N/A | -1644.8% |
| All | -$702.60K | -5992.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$43.97M | +2.6% | |
| 3Y | -$43.97M | +2.6% | |
| 5Y | -$43.97M | +2.6% | |
| All | -$43.97M | +2.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CELC?
As of today, CELC quarterly EBITDA is -$42.81M
What is CELC quarterly EBITDA most recent change?
CELC quarterly EBITDA was up +2.64% on September 30, 2025
What is 1-year change in CELC quarterly EBITDA?
CELC quarterly EBITDA is down -42.57% year-over-year
How far is CELC quarterly EBITDA from its all-time high?
CELC quarterly EBITDA is currently -5992.80% below its historical high of -$702.60K set on March 1, 2016
How does CELC quarterly EBITDA rank versus sector peers?
CELC quarterly EBITDA is higher than 9.30% of companies in Healthcare sector
When is CELC next earnings release?
The next earnings release for CELC is on
TTM EBITDA
-$159.27M$12.78M-8.73%
Summary
- Current Value
- As of today, CELC TTM EBITDA is -$159.27M, down -8.73% on
- Historical Performance
- CELC TTM EBITDA is down -65.14% year-over-year, and down -370.54% over the past 3 years
- All-Time High Comparison
- CELC TTM EBITDA is currently -22568.36% below its historical high of -$702.60K set on
- 3-Year Low Comparison
- CELC TTM EBITDA is at its 3-year low
- Sector Comparison
- CELC TTM EBITDA is higher than 10.21% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$159.27M | -8.7% | -65.1% | -370.5% | -1769.0% | |
| Annual EBITDA | -$101.37M | – | -73.8% | -261.5% | -1344.0% | |
| Quarterly EBITDA | -$42.81M | +2.6% | -42.6% | -304.2% | -1696.0% | |
| Price | $104.67 | +111.5% | +724.2% | +770.1% | +822.2% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| TTM EPS | -$3.67 | -6.5% | -40.8% | -54.2% | -331.4% | |
| TTM EBIT | -$159.42M | -8.7% | -65.1% | -367.9% | -1690.7% | |
| TTM Net Income | -$162.72M | -9.4% | -73.2% | -357.8% | -1763.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$113.14M | N/A | -40.8% |
| 3Y | -$39.18M | N/A | -306.5% |
| 5Y | -$9.17M | N/A | -1636.7% |
| All | -$702.60K | >-9999.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$159.27M | at low | |
| 3Y | -$159.27M | at low | |
| 5Y | -$159.27M | at low | |
| All | -$159.27M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CELC?
As of today, CELC TTM EBITDA is -$159.27M
What is CELC TTM EBITDA most recent change?
CELC TTM EBITDA was down -8.73% on September 30, 2025
What is 1-year change in CELC TTM EBITDA?
CELC TTM EBITDA is down -65.14% year-over-year
How far is CELC TTM EBITDA from its all-time high?
CELC TTM EBITDA is currently -22568.36% below its historical high of -$702.60K set on March 1, 2016
How does CELC TTM EBITDA rank versus sector peers?
CELC TTM EBITDA is higher than 10.21% of companies in Healthcare sector
When is CELC next earnings release?
The next earnings release for CELC is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- CELC Official Website www.celcuity.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1603454/000149315225022401/0001493152-25-022401-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1603454/000164117225001826/0001641172-25-001826-index.htm
- CELC Profile on Yahoo Finance finance.yahoo.com/quote/CELC
- CELC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/celc